海翔药业：公司员工持股计划及回购事项请关注公司相关公告

Group 1 - The company, Haixiang Pharmaceutical, stated on September 25 that it strictly complies with the relevant laws and regulations of the China Securities Regulatory Commission and the Shenzhen Stock Exchange regarding information disclosure obligations [2] - The company mentioned that investors should pay attention to relevant announcements regarding its employee stock ownership plan and share repurchase matters [2]